公开(公告)号：US20170298361A1

公开(公告)日：2017-10-19

申请号：US15516405

申请日：2015-10-01

Applicant: Yeda Research and Development Co. Ltd.

Inventor： Yosef SHAUL ,  Rom David KESHET ,  Nina REUVEN

IPC: C12N15/113 ,  A61K31/506 ,  A61K31/553

CPC classification number: C12N15/1137 ,  A61K31/506 ,  A61K31/553 ,  C12N2310/14 ,  C12N2310/531

Abstract: Use of agents that down-regulates an amount and/or activity of Abelson murine leukemia viral oncogene homolog 1 (c-Abl) or checkpoint kinase 1 (Chk1) in the production of a medicament for treating obesity are disclosed.